Bayban’s Merck MRK Stock Holding History

Bayban’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	2,139 +200	+10%	+$23.4K	0.21%	81
2026 Q1	$233K	Sell	1,939 -38	-2%	-$4.39K	0.2%	85
2025 Q4	$208K	Buy	+1,977	New	+$186K	0.18%	93

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayban's MRK Position: Q2 2026 in Review

Bayban increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $23.4K and bringing the position to 2,139 shares worth $275K. The position accounts for 0.21% of the portfolio, ranked #81.

Bayban first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Bayban held 2,139 shares of Merck worth $275K as of Q2 2026.
Bayban bought 200 Merck shares in Q2 2026, an estimated $23.4K.
Merck made up 0.21% of Bayban's portfolio in Q2 2026, its #81 holding.
Bayban first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.